07.04.2010 • NewsAkzoNobelIndiaICI

Akzo Nobel Rebrands Indian ICI business

Akzo Nobel's integration activities following the acquisition of ICI have reached a significant landmark with the ICI India business now officially known as Akzo Nobel India Limited. ICI India, a separate listed company on the stock market, is one of the country's leading decorative paints businesses. Led by Managing Director Amit Jain under the same Board of Directors, the rebranded business will continue to play a pivotal role in the company's strategic growth plans.

"We are delighted that ICI India has now officially taken on the AkzoNobel name," said CEO Hans Wijers. "India is a very important market for us and we are now well prepared to take full advantage of the world class capabilities of our Indian decorative paints organization and build on our promising market position."

He added that AkzoNobel plans to make major investments in India during the next five years to boost the opportunities in this high-growth market. "The change in identity is just the beginning of a wave of strategic investments which we plan to make in people, practices, new ways of marketing, technology and research," continued Wijers.

Company

Logo:

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read